NETHERLANDS |AS |EUR
Koninklijke DSM N.V., a science-based company, engages in nutrition, health, and sustainable living businesses in the Netherlands, rest of Europe, North America, Latin America, China, India, Japan, rest of Asia, and internationally. It operates through Nutrition, Materials, and Innovation Center segments. The Nutrition segment offers animal nutrition and health products, including vitamins, enzymes, eubiotics, carotenoids, lipids, and minerals; human nutrition and health products comprising carotenoids, digestive enzymes, nutritional lipids, nutraceuticals, probiotic and prebiotics, and vitamins; and skin and sun care, hair care, and aroma ingredients. It also provides vitamin and lipid active pharmaceutical ingredients; omega-3 fatty acids; specialty enzymes, cultures, probiotics, bio-preservation, sugar reduction, and savory taste solutions; and specialty hydrocolloid solutions. The Materials segment provides thermoplastics used in automotive, electrical and electronics, building and construction, medical, food packaging, and consumer goods; coating resins and functional materials; Dyneema, a fiber solution for use in aviation, personal protection, marine, fishing, heavy lifting, and sports and lifestyle industries; and additives. The Innovation Center segment offers biomedical materials, and medical device and material manufacturing technologies in the areas of cardiovascular, dental, diabetes management, gynecology, neurology, ophthalmology, orthopedic, plastic and reconstructive surgery, soft tissue, and wound management. It also provides anti-reflective (AR) coatings for solar glass, retrofit AR and anti-soiling coatings, and conductive and PV backsheets; and yeast and enzymes for the conversion of starch, corn fiber, and biomass. The company has a partnership with Strait Access Technologies to develop trans-catheter replacement heart valves with polymeric leaflets. Koninklijke DSM N.V. was founded in 1902 and is headquartered in Heerlen, the Netherlands.
| Shares Outstanding | 172.97M | Beta | 0.63 |
|---|---|---|---|
| Public Float | 172.56M | P/E Ratio | 15.46 |
| % Short of Float | - | Dividend (Yield) | 2.50 (0.02%) |
| Held by Insiders | 0.22% | Ex-Dividend Date | May 12, 2022 |
| Held by Institutions | 56.38% | IPO Date | - |
| Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|
| Revenue | €9.20B | €8.11B | €9.01B |
| EBITDA | €1.71B | €1.43B | €1.60B |
| Net Income | €1.68B | €506.00M | €758.00M |
| Total Assets | €16.01B | €14.36B | €13.44B |
| Total Cash | €1.56B | €871.00M | €1.49B |
| Total Debt | € | € | € |
| Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|
| Revenue | € | € | € |
| EBITDA | € | € | € |
| Net Income | € | € | € |
| Total Assets | €16.01B | € | €15.10B |
| Total Cash | €1.56B | € | €1.64B |
| Total Debt | € | € | € |
| Year | Open | Close | Change |
|---|---|---|---|
| 2021 | €198.10 | €144.95 | -26.83% |
| 2021 | €142.95 | €198.10 | 38.58% |
| 2020 | €115.30 | €142.95 | 23.98% |
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Jun 17, 2022 | €140.95 | €142.90 | €138.55 | €138.55 | -2.33% | 1.10M |
| Jun 14, 2022 | €151.55 | €151.55 | €141.85 | €141.85 | -9.25% | 574.35K |
| Jun 9, 2022 | €155.85 | €156.90 | €154.85 | €156.30 | -0.22% | 445.51K |
For the last quarterly earnings period (ended on March 31, 2022) DSM reported €1.32 EPS for the quarter, missing the average analysts’ forecasts of €1.36 EPS by €-0.04 (-2.94%).
View More Details on Koninklijke dsm's 'Earnings' Section
Koninklijke dsm is expected to report earnings on August 02 ,2022.
View More Details on Koninklijke dsm's 'Earnings' Section
Koninklijke dsm trades on the Euronext Amsterdam stock market in Netherlands under the ticker symbol "DSM". Koninklijke dsm’s stock symbol can also be displayed as "AMS:DSM".
Koninklijke dsm (AMS:DSM) is owned by 56.38% institutional shareholders and by 0.22% insiders. The rest is owned by the public.
Explore More Details on Koninklijke dsm's “Ownership” Section
Koninklijke dsm's key executive team includes the following managers:
Koninklijke dsm (AMS:DSM) is classified under the "Basic Materials" sector and under the "Specialty Chemicals" industry.
ESG scores assess the degree to which a company’s enterprise business value is at risk driven by environmental, social, and governance issues. The scores are a measure of risk on an absolute scale of 0-100, with a lower score meaning less risk.
DSM’s total ESG score is 17.62. The company’s environmental score is 8.20, social score is 1.46 and governance score is 3.47.
Koninklijke dsm (AMS:DSM) is involved in the following activities (which decreases its ESG score) : "animalTesting".
Currently the number of employees working for Koninklijke dsm is 21,358.
Koninklijke dsm (AMS:DSM) is headquartered in Netherlands.
Koninklijke dsm’s mailing address is Het Overloon 1, Heerlen, Netherlands, 6411 TE.
The company’s phone number is 31 45 578 8111.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.
